Company: CLX
Filing Date: 2025-02-03
Form Type: 10-Q
Source: 0000021076-25-000013
Chunk: 101

Company: CLOROX CO /DE/
Filing Date: 2025-02-03
Form: 10-Q
Item: Part I, Item 2
Chunk 101
---
 & Divestitures (1)Foreign Exchange ImpactPrice/Mix/ Other (2)Organic Sales Growth / (Decrease) (Non-GAAP) (3)Organic Volume (4)Health and Wellness(13)%(11)%— %— %(2)%(13)%(11)%Household(11)(11)— — — (11)(11)Lifestyle(16)(16)— — — (16)(16)International (4)(12)(12)(16)(2)2 6 6 Total Company (4)(5)(15)%(15)%(6)%— %— %(9)%(8)%Six months ended December 31, 2024Percentage change versus the year-ago periodReported (GAAP) Net Sales Growth / (Decrease)Reported VolumeAcquisitions & Divestitures (1)Foreign Exchange ImpactPrice/Mix/Other (2)Organic Sales Growth / (Decrease) (Non-GAAP) (3)Organic Volume (4)Health and Wellness8 %10 %— %— %(2)%8 %10 %Household8 10 — — (2)8 10 Lifestyle4 5 — — (1)4 5 International (4)(8)(9)(14)(2)3 8 8 Total Company (4)(5)2 %2 %(5)%— %— %7 %8 %

(1)The divestiture impact is calculated as net sales from the Argentina and Better Health VMS businesses after the respective sale dates in the three and six month year-ago periods.

(2)This represents the net impact on net sales growth / (decrease) from pricing actions, mix, trade promotion spending, mix from acquisitions and divestitures and other factors. In the three months ended December 31, 2024, the impact from divestiture mix was 2% and 1% for International and Total Company, respectively. In the six months ended December 31, 2024, the impact from divestiture mix was 3% and 1% for International and Total Company, respectively.

(3)Organic sales growth / (decrease) is defined as net sales growth / (decrease) excluding the effect of any acquisitions and divestitures and foreign exchange rate changes. See “Non-G